
Biotechnology • Pharmaceuticals
Dynavax Technologies is a commercial-stage biopharmaceutical company focused on developing and commercializing novel vaccines to combat infectious diseases. The company utilizes proven and innovative adjuvant technology, such as its CpG 1018® adjuvant, to enhance the effectiveness of vaccines, including its HEPLISAV-B® product. With a commitment to making a global impact on public health, Dynavax actively engages in clinical trials and values driven team collaborations to advance its pipeline of vaccine solutions.
201 - 500 employees
Founded 1996
🧬 Biotechnology
💊 Pharmaceuticals
💰 $200M Post-IPO Debt on 2021-05
November 7
Director overseeing CMC initiatives in biopharmaceuticals, leading drug substance development for vaccine projects. Collaborating cross-functionally to ensure project delivery and regulatory compliance.
🏄 California – Remote
💵 $214k - $232k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🔴 Lead
👔 Director
October 29
Senior Director leading retail marketing initiatives and managing operations for HEPLISAV-B at Dynavax. Fostering collaboration and driving marketing success in the biopharmaceuticals industry.
🏄 California – Remote
💵 $275k - $301k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🟠 Senior
⚙️ Operations
October 7
Clinical Research Associate II executing clinical studies for Dynavax, a biopharmaceutical company developing vaccines to protect against infectious diseases. Ensuring compliance with regulations, coordinating study efforts, and managing clinical trial activities.
🏄 California – Remote
💵 $75 / hour
💰 $200M Post-IPO Debt on 2021-05
⏳ Contract/Temporary
🟢 Junior
🟡 Mid-level
🔬 Research Analyst
September 24
Lead enterprise Data and AI architecture and cloud migration at Dynavax, a vaccine biopharma. Design AI-ready data foundations and governance to enable analytics and MLOps.
🏄 California – Remote
💵 $261k - $289k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🟠 Senior
🤖 AI Engineer